Correlation Between GlaxoSmithKline PLC and Janus Enterprise
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Janus Enterprise at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Janus Enterprise into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Janus Enterprise Fund, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Janus Enterprise and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Janus Enterprise. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Janus Enterprise.
Diversification Opportunities for GlaxoSmithKline PLC and Janus Enterprise
-0.79 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between GlaxoSmithKline and JANUS is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Janus Enterprise Fund in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Janus Enterprise and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Janus Enterprise. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Janus Enterprise has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Janus Enterprise go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Janus Enterprise
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Janus Enterprise. In addition to that, GlaxoSmithKline PLC is 1.59 times more volatile than Janus Enterprise Fund. It trades about -0.31 of its total potential returns per unit of risk. Janus Enterprise Fund is currently generating about 0.29 per unit of volatility. If you would invest 14,258 in Janus Enterprise Fund on August 29, 2024 and sell it today you would earn a total of 797.00 from holding Janus Enterprise Fund or generate 5.59% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Janus Enterprise Fund
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Janus Enterprise |
GlaxoSmithKline PLC and Janus Enterprise Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Janus Enterprise
The main advantage of trading using opposite GlaxoSmithKline PLC and Janus Enterprise positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Janus Enterprise can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Janus Enterprise will offset losses from the drop in Janus Enterprise's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Janus Enterprise vs. Janus Forty Fund | Janus Enterprise vs. Janus Enterprise Fund | Janus Enterprise vs. Janus Triton Fund | Janus Enterprise vs. Janus Balanced Fund |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |